These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21293984)

  • 1. The consequences of post-election violence on antiretroviral HIV therapy in Kenya.
    Pyne-Mercier LD; John-Stewart GC; Richardson BA; Kagondu NL; Thiga J; Noshy H; Kist N; Chung MH
    AIDS Care; 2011 May; 23(5):562-8. PubMed ID: 21293984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of post-election violence on HIV and other clinical services and on mental health-Kenya, 2008.
    Bamrah S; Mbithi A; Mermin JH; Boo T; Bunnell RE; Sharif S; Cookson ST
    Prehosp Disaster Med; 2013 Feb; 28(1):43-51. PubMed ID: 23177022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time series analysis of sexual assault case characteristics and the 2007-2008 period of post-election violence in Kenya.
    Anastario MP; Adhiambo Onyango M; Nyanyuki J; Naimer K; Muthoga R; Sirkin S; Barrick K; van Hasselt M; Aruasa W; Kibet C; Omollo G
    PLoS One; 2014; 9(8):e106443. PubMed ID: 25170917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term impact of the Kenya postelection crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya.
    Yoder RB; Nyandiko WM; Vreeman RC; Ayaya SO; Gisore PO; Braitstein P; Wiehe SE
    J Acquir Immune Defic Syndr; 2012 Feb; 59(2):199-206. PubMed ID: 22027872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for interruption in treatment among HIV-infected adolescence attending health care and treatment clinics in Tanzania.
    Mtisi EL; Mushy SE; Mkawe SG; Ndjovu A; Mboggo E; Mlay BS; Ngalesoni F; Muya A
    AIDS Res Ther; 2023 Mar; 20(1):19. PubMed ID: 36998051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.
    Haile D; Takele A; Gashaw K; Demelash H; Nigatu D
    PLoS One; 2016; 11(10):e0164299. PubMed ID: 27716827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya.
    Vreeman RC; Nyandiko WM; Sang E; Musick BS; Braitstein P; Wiehe SE
    Confl Health; 2009 Apr; 3():5. PubMed ID: 19344523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
    Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
    J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors.
    Boyer S; Clerc I; Bonono CR; Marcellin F; Bilé PC; Ventelou B
    Soc Sci Med; 2011 Apr; 72(8):1383-92. PubMed ID: 21470734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 11. Partner Disclosure and Early CD4 Response among HIV-Infected Adults Initiating Antiretroviral Treatment in Nairobi Kenya.
    Trinh TT; Yatich N; Ngomoa R; McGrath CJ; Richardson BA; Sakr SR; Langat A; John-Stewart GC; Chung MH
    PLoS One; 2016; 11(10):e0163594. PubMed ID: 27711164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of non-communicable diseases among key populations enrolled at a large HIV prevention & treatment program in Kenya.
    Achwoka D; Oyugi JO; Mutave R; Munywoki P; Achia T; Akolo M; Muriuki F; Muthui M; Kimani J
    PLoS One; 2020; 15(7):e0235606. PubMed ID: 32614906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainability of first-line antiretroviral regimens: findings from a large HIV treatment program in western Kenya.
    Braitstein P; Ayuo P; Mwangi A; Wools-Kaloustian K; Musick B; Siika A; Kimaiyo S
    J Acquir Immune Defic Syndr; 2010 Feb; 53(2):254-9. PubMed ID: 19745752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
    Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
    Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for HIV infection among asymptomatic pregnant women attending an antenatal clinic in western Kenya.
    Ayisi JG; van Eijk AM; ter Kuile FO; Kolczak MS; Otieno JA; Misore AO; Kager PA; Steketee RW; Nahlen BL
    Int J STD AIDS; 2000 Jun; 11(6):393-401. PubMed ID: 10872913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "I just believe there is a risk" understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya.
    Ngure K; Ongolly F; Dolla A; Awour M; Mugwanya KK; Irungu E; Mugo N; Bukusi EA; Morton J; Odoyo J; Wamoni E; Barnabee G; Peebles K; O'Malley G; Baeten JM;
    J Int AIDS Soc; 2020 Mar; 23(3):e25466. PubMed ID: 32144888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.
    Duber HC; Dansereau E; Masters SH; Achan J; Burstein R; DeCenso B; Gasasira A; Ikilezi G; Kisia C; Masiye F; Njuguna P; Odeny T; Okiro E; Roberts DA; Gakidou E
    PLoS One; 2015; 10(3):e0120350. PubMed ID: 25807553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.